UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 4, 2023
Accession Number:
0001437749-23-008504
Submission Type:
POS AM
CIK:
0001742927
Company Name:
REVIVA PHARMACEUTICALS HOLDINGS, INC.
File Number:
333-267762